Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Strategy
MSTR
US Stock MarketDetailed Quotes
AVXL Anavex Life Sciences
- 8.990
- +0.320+3.69%
Close Mar 10 16:00 ET
- 8.980
- -0.010-0.11%
Post 19:55 ET
764.73MMarket Cap-16.35P/E (TTM)
9.248High8.410Low909.09KVolume8.460Open8.670Pre Close8.12MTurnover1.10%Turnover RatioLossP/E (Static)85.06MShares14.44152wk High6.89P/B741.45MFloat Cap3.25052wk Low--Dividend TTM82.47MShs Float31.500Historical High--Div YieldTTM9.66%Amplitude0.600Historical Low8.927Avg Price1Lot Size
Anavex Life Sciences News
Anavex Life Sciences | 10-Q: Q1 2025 Earnings Report
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Boenisch Sandra
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Boenisch Sandra
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 10-K: FY2024 Annual Report
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Boenisch Sandra
Anavex Life Sciences | 10-Q: Q3 2024 Earnings Report
Anavex Life Sciences | 8-K: Current report
Anavex Life Sciences | S-3: Registration statement for specified transactions by certain issuers
Anavex Life Sciences | 8-K: Current report
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Donhauser Peter D.O.
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Thomas Steffen
Anavex Life Sciences | 10-Q: Q2 2024 Earnings Report
Anavex Life Sciences | 8-K: Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update
Anavex Life Sciences | DEF 14A: Definitive information statements
Anavex Life Sciences | DEFA14A: Others
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 144: Notice of proposed sale of securities pursuant to Rule 144